Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Dimemebfe

From Wikipedia, the free encyclopedia
Dimemebfe
Clinical data
Other names5-Methoxy-N,N-dimethyl-3-(2-aminoethyl)benzofuran; N,N-Dimethyl-5-methoxy-benzofuranylethylamine; 5-MeO-BFE; 5-MeO-DMBF; 1-Oxa-5-MeO-DMT; O-5-MeO-DMT; "Head f--k"; "Head fuck"
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
  • US: Unscheduled and not FDA approved
Identifiers
  • 2-(5-Methoxy-1-benzofuran-3-yl)-N,N-dimethylethanamine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H17NO2
Molar mass219.284 g·mol−1
3D model (JSmol)
  • CN(C)CCc1coc(c1c2)ccc2OC
  • InChI=1S/C13H17NO2/c1-14(2)7-6-10-9-16-13-5-4-11(15-3)8-12(10)13/h4-5,8-9H,6-7H2,1-3H3 X markN
  • Key:WBPQJTBOQCCTFX-UHFFFAOYSA-N X markN
 X markNcheckY (what is this?)  (verify)

Dimemebfe, also known as 5-methoxy-N,N-dimethyl-3-(2-aminoethyl)benzofuran (5-MeO-BFE or 5-MeO-DMBF) or as 1-oxa-5-MeO-DMT, is a psychedelic drug of the benzofuran family related to the psychedelic tryptamine 5-MeO-DMT.[1][2][3][4] It is the analogue and bioisostere of 5-MeO-DMT in which the nitrogen atom of the indole ring has been replaced with an oxygen atom, making dimemebfe a benzofuran rather than tryptamine derivative.[1][2][3][4] The drug has been encountered as a novel designer drug.[3]

Interactions

[edit]

Pharmacology

[edit]

Pharmacodynamics

[edit]

Dimemebfe acts as an agonist of the serotonin 5-HT1A and 5-HT2 family of serotonin receptors.[4] It is several times less potent as a serotonin receptor agonist than 5-MeO-DMT and with relatively more activity at the serotonin 5-HT1A receptor, but still shows strongest actions at the 5-HT2 family of receptors.[4]

Chemistry

[edit]

Synthesis

[edit]

The chemical synthesis of dimemembfe has been described.[4]

Analogues

[edit]

Analogues of dimemebfe include the benzofurans 5-MeO-DiBF (1-oxa-5-MeO-DiPT), 3-APB (1-oxa-AMT), and mebfap (5-MeO-3-APB; 1-oxa-5-MeO-AMT), the benzothiophene S-DMT (1-thia-DMT), and the tryptamine 5-MeO-DMT, among others.

History

[edit]

Dimemebfe was first described in the scientific literature by David E. Nichols and colleagues in 1992.[3][4] Subsequently, it emerged as a novel designer drug by 2012.[3]

Society and culture

[edit]
[edit]

Canada

[edit]

Dimemebfe is not a controlled substance in Canada as of 2025.[5]

United States

[edit]

Dimemebfe is not an explicitly controlled substance in the United States.[6] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

Dimemebfe is a Schedule I controlled substance in the United States state of Alabama.[7]

See also

[edit]

References

[edit]
  1. 1 2 Nichols, David E. (2012). "Structure–activity relationships of serotonin 5‐HT 2A agonists". Wiley Interdisciplinary Reviews: Membrane Transport and Signaling. 1 (5): 559–579. doi:10.1002/wmts.42. ISSN 2190-460X. Retrieved 7 January 2026.
  2. 1 2 Nichols DE (2018). "Chemistry and Structure-Activity Relationships of Psychedelics". Curr Top Behav Neurosci. 36: 1–43. doi:10.1007/7854_2017_475. PMID 28401524.
  3. 1 2 3 4 5 Casale JF, Hays PA (2012). "The Characterization of 2-(5-Methoxy-1-benzofuran-3-yl)-N,N-dimethylethanamine (5-MeO-BFE) and Differentiation from its N-Ethyl Analog" (PDF). Microgram Journal. 9 (1): 39–45. Archived from the original (PDF) on 2017-05-13. Retrieved 2015-02-23.
  4. 1 2 3 4 5 6 Tomaszewski Z, Johnson MP, Huang X, Nichols DE (May 1992). "Benzofuran bioisosteres of hallucinogenic tryptamines". Journal of Medicinal Chemistry. 35 (11): 2061–2064. doi:10.1021/jm00089a017. PMID 1534585.
  5. "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
  6. Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF), United States: U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division, January 2026
  7. "Alabama Senate Bill 333 - Controlled substances, Schedule I, additional synthetic controlled substances and analogue substances included in, trafficking in controlled substance analogues, requisite weight increased, Secs. 13A-12-231, 20-2-23 am'd". March 2014. Retrieved 28 September 2015.
[edit]